CoChat

Mechanism of the Cardiotoxic Actions of Terfenadine

Woosley, Raymond L. · 1993 · JAMA: The Journal of the American Medical Association

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Abstract

OBJECTIVES AND METHODS: To gain insight into possible mechanisms of and predisposing factors for torsades de pointes during terfenadine therapy, spontaneous reports in the US Food and Drug Administration's Spontaneous Reporting System database were examined. Based on the characteristics of the cases, in vitro cardiac electrophysiologic studies were conducted to test the hypothesis that terfenadine, and not its major metabolite, has actions similar to those of quinidine and is responsible for this form of cardiac toxicity. DESIGN: Spontaneous reports from the general medical community. RESULTS: As of April 1, 1992, 25 cases of torsades de pointes had been reported to the Food and Drug Administration's Spontaneous Reporting System. Predisposing factors in these cases indicated that the parent drug, but not its metabolite, may have actions similar those of quinidine that are responsible for inducing arrhythmia. In vitro studies found that terfenadine is equipotent to quinidine as a blocker of the delayed rectifier potassium current in isolated feline myocytes. The metabolite, terfenadine carboxylate, did not inhibit this potassium current even at concentrations 30 times higher than the concentration of terfenadine producing a half-maximal effect. CONCLUSIONS: Since blockade of the potassium channel did not occur with the major metabolite of terfenadine, episodes of torsades de pointes are most likely the result of a quinidinelike action of the parent drug and of factors that impair the normally rapid metabolism of terfenadine. Dosage restriction and awareness of the clinical conditions and drug interactions capable of inhibiting the metabolism of terfenadine are essential for prevention of this serious reaction.

Overview

Integrity signals

Registry

Crossref · 10.1001/jama.1993.03500120070028

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 25 references

Cited by

See all 646

Metadata

Authors
Woosley, R. L.
Affiliations
Georgetown University Medical Center (US)
Corresponding author
Woosley, Raymond L.
Venue
JAMA: The Journal of the American Medical Association
Published
1993-03-24
Volume
269
Issue
12
Pages
1532
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2052085254
Cited by
646
References
26
Citations by year
2026: 5 · 2025: 1 · 2024: 2 · 2023: 10 · 2022: 5 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 7 · 2017: 11 · 2016: 15 · 2015: 8 · 2014: 20 · 2013: 17 · 2012: 16
FWCI
33.54
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
terfenadine, torsades de pointes, cardiotoxicity, delayed rectifier potassium current, drug metabolites, drug interactions, drug metabolism inhibition, cardiac arrhythmias, adverse drug reactions
MeSH terms
Adolescent, Adult, Aged, Animals, Cats, Dose-Response Relationship, Drug, Female, Heart, Humans, Male, Middle Aged, Myocardium, Quinidine, Vectorcardiography, Potassium Channels, Torsades de Pointes, Terfenadine, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of the Cardiotoxic Actions of Terfenadine. https://app.cochat.ai/papers/10.1001/jama.1993.03500120070028
The paper
Woosley, R. L. (1993). Mechanism of the Cardiotoxic Actions of Terfenadine. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1993.03500120070028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.